| Abby Tomlin, PT, DPT | |
|
1105 Earl Frye Blvd, Amory, MS 38821-5500 | |
| (662) 256-6124 | |
| Not Available |
| Full Name | Abby Tomlin |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 1105 Earl Frye Blvd, Amory, Mississippi |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396452678 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 6714 (Mississippi) | Primary |
| Provider Name | Breakthrough Physical Therapy |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1396522736 PECOS PAC ID: 3971959099 Enrollment ID: O20231026001241 |
News Archive
BioNeutral Group Inc., a specialty chemical technology-based life science company, today announced financial results for the third quarter and nine-month period ended July 31, 2010.
Researchers from Belgium and Germany demonstrated how the spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is fine-tuned towards the temperature and protease conditions of the human airways, which in turn enhances viral transmission and subsequent pathology. Their study is available on the bioRxiv* preprint server.
HealthPort, a top-25 company in the healthcare information technology industry, today announced that National Health Services, Inc. (NHSI), a 12-site Federally Qualified Health Center (FQHC) with locations throughout Kern County, California, has achieved 100% provider adoption of HealthPort's Electronic Medical Record (EMR) technology.
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals International GmbH, today announced that the European Commission has granted Marketing Authorisation for Entyvio (vedolizumab), a gut-selective humanized monoclonal antibody, and the first and only biologic therapy to be approved simultaneously for the treatment of adults with moderately to severely active ulcerative colitis (UC) and adults with moderately to severely active Crohn's disease (CD) who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a tumor necrosis factor-alpha (TNFα) antagonist.
Washing with soap and water is second nature for many. But in many other places around the world, handwashing with soap is rare.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Abby Tomlin, PT, DPT 1105 Earl Frye Blvd, Amory, MS 38821-5500 Ph: (662) 256-6124 | Abby Tomlin, PT, DPT 1105 Earl Frye Blvd, Amory, MS 38821-5500 Ph: (662) 256-6124 |
News Archive
BioNeutral Group Inc., a specialty chemical technology-based life science company, today announced financial results for the third quarter and nine-month period ended July 31, 2010.
Researchers from Belgium and Germany demonstrated how the spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is fine-tuned towards the temperature and protease conditions of the human airways, which in turn enhances viral transmission and subsequent pathology. Their study is available on the bioRxiv* preprint server.
HealthPort, a top-25 company in the healthcare information technology industry, today announced that National Health Services, Inc. (NHSI), a 12-site Federally Qualified Health Center (FQHC) with locations throughout Kern County, California, has achieved 100% provider adoption of HealthPort's Electronic Medical Record (EMR) technology.
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals International GmbH, today announced that the European Commission has granted Marketing Authorisation for Entyvio (vedolizumab), a gut-selective humanized monoclonal antibody, and the first and only biologic therapy to be approved simultaneously for the treatment of adults with moderately to severely active ulcerative colitis (UC) and adults with moderately to severely active Crohn's disease (CD) who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a tumor necrosis factor-alpha (TNFα) antagonist.
Washing with soap and water is second nature for many. But in many other places around the world, handwashing with soap is rare.
› Verified 6 days ago
Jamee Fratesi Zepponi, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1111 Earl Frye Blvd, Amory, MS 38821 Phone: 662-257-4048 Fax: 662-257-4080 | |
Zachary James Randolph, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 60368 Cotton Gin Port Rd, Amory, MS 38821 Phone: 662-257-3669 Fax: 662-257-3961 | |
Kelly Coker Dabbs, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1215 Earl Frye Blvd, Amory, MS 38821 Phone: 662-256-4640 | |
Melinda Dickerson, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 404 Peg Ln, Amory, MS 38821 Phone: 662-315-0084 Fax: 479-709-7717 | |
Kacey Byrd Roberts, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1112 Highway 278 E Ste A, Amory, MS 38821 Phone: 662-257-4048 Fax: 662-257-7080 | |
Justin Lee Knight, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1111 Earl Frye Blvd, Amory, MS 38821 Phone: 662-257-4048 Fax: 662-257-4080 | |
Alyson Rae Key, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1111 Earl Frye Blvd, Amory, MS 38821 Phone: 662-257-4048 Fax: 662-257-4080 |